References
- 1. A. E. Yassin, A. H. Aodah, S. Al-Suwayeh and E. I. Taha, Theophylline colon specific tablets for chronotherapeutic treatment of nocturnal asthma, Pharm. Dev. Technol. 17 (2012) 712–718; DOI: 10.3109/10837450.2011.572896.
- 2. K. P. Pagar and P. R. Vavia, Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension, Acta Pharm. 62 (2012) 395–410. DOI: 10.2478/v10007-012-0023-0.
- 3. V. D. Kadam and S. G. Gattani, Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependent polymers, Pharm. Dev. Technol.15 (2010) 57–63; DOI: 10.3109/10837450902980254.
- 4. R. C. Hermida, D. E. Ayala, C. Calvo, F. Portaluppi and M. H. Smolensky, Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure, Adv. Drug Deliv. Rev.59 (2007) 923–39; DOI: 10.1016/j.addr.2006.09.021
- 5. F. Portaluppi, R. Tiseo, M. H. Smolensky, R. C. Hermida, D. E. Ayala and F. Fabbian, Circadian rhythms and cardiovascular health, Sleep Med. Rev.16(2) (2012) 151–166; DOI: 10.1016/j.smrv.2011.04.003.
- 6. A. El Sayeh, F. Abou el Ela, E. H. Ibrahim and A. A. Allam, Bucco-adhesive tablets containing metoprolol tartarate: formulation, in vitro and in vivo characterization, J. Drug Del. Sci. Tech.23 (2013) 171–179; DOI: 10.1016/S1773-2247(13)50026-8.
- 7. H. Ravishankar, P. Patil, A. Samel, H. U. Petereit, R. Lizio and J. Iyer-Chavan, Modulated release metoprolol succinate formulation based on ionic interactions: In vivo proof of concept, J. Control. Release111 (2006) 65–72; DOI: 10.1016/j.jconrel.2005.12.007.
- 8. R. C. Hermida, D. E. Ayala and F. Portaluppi, Circadian variation of blood pressure: The basis for the chronotherapy of hypertension, Adv. Drug Deliv. Rev.59 (2007) 904–922; DOI: 10.1016/j.addr.2006.08.003.
- 9. D. A. Taylor and A. A. Abdel-Rahman, Novel strategies and targets for the management of hypertension, Adv. Pharmacol.57 (2009) 291–345; DOI: 10.1016/S1054-3589(08)57008-6.
- 10. T. Bussemer and R. A. Bodmeier, Drug Delivery Pulsatile Systems, in Encyclopaedia of Pharmaceutical Technology (Ed. J. Swarbrick) 3rd ed., Informa Healthcare, New York 2007, pp. 1287–1297.
- 11. A. Maroni, L. Zema, G. Loreti, L. Palugan and A. Gazzaniga, Film coatings for oral pulsatile release, Int. J. Pharm.457 (2013) 362–371; DOI: 10.1016/j.ijpharm.2013.03.010.
- 12. L. Palugan, M. Cerea, L. Zema, A. Gazzaniga and A Maroni, Coated pellets for oral colon delivery, J. Drug Del. Sci. Tech.25 (2015) 1–15; DOI: 10.1016/j.jddst.2014.12.003
- 13. Y. Zhang, M. Huo, J. Zhou, A. Zou, Li W, Yao C and Xie S, DDSolver: an add-in program for modeling and comparison of drug dissolution profiles, AAPS J.12 (2010) 263–71; DOI: 10.1208/s12248-010-9185-1.
- 14. S. Dash, P. N. Murthy, L. Nath and P. Chowdhury, Kinetic modeling on drug release from controlled drug delivery systems, Acta Pol. Pharm.67 (2010) 217–223.
- 15. Y. Liu, S. Liu, Q. Dai, Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate, Chem. Pharm. Bull.7 (2009) 55–60; DOI: 10.1248/cpb.57.55.
- 16. Sigma Plot 11, Statistical User Guide Manual, Systat Software Inc, 2008.
- 17. A. L. Vonica, I. Tomuţă and S. E. Leucuţa, Experimental design for the screening of three types of coating polymers for metoprolol minitablets with pulsatile release, Farmacia59 (2011) 742–749.
- 18. I. Tomuţă, C. Alecu, L. L. Rus and S. E. Leucuţa, Optimization of fluid bed formulations of metoprolol granules and tablets using an experimental design, Drug Dev. Ind. Pharm.35 (2009) 1072–1081; DOI: 10.1080/03639040902774149.
- 19. European Pharmacopoeia 8.2. Online Edition 2014.
- 20. S. Varigonda, T. T. Georgiou, R. A. Siegel and P. Daoutidis, Optimal periodic control of a drug delivery system, Comput. Chem. Eng.32 (2008) 2256–2262; DOI: 10.1016/j.compchemeng.2007.11.003.
- 21. H. Wang, J. Li and Y. Kuang, Mathematical modeling and quantitative analysis of insulin therapies, Math. Biosci.210 (2007) 17–33; DOI: 10.1016/j.mbs.2007.05.008.
- 22. L. Eriksson, E. Johansson, N. Kettaneh-Wold, C. Wikström and S. Wold, Design of Experiments, Principles and Applications, 3rd ed., Umetrics Academy, Umea 2008.
- 23. MODDE 10. Software for Design of Experiments and Optimization: User’s Guide and Tutorial. Umetrics Academy, Umea 2014.
- 24. I. Tomuţă and S.E. Leucuta, Development and in vitro evaluation of multiparticulate sustained release carbamazepine formulation, Acta Pol. Pharm.69 (2012) 951–964.
- 25. S. F. Hung, C. M. Hsieh, Y. C. Chen, C. M. Lin, H. O. Ho and M. T. Sheu, Formulation and process optimization of multiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane, Int. J. Pharm.480 (2015) 15–26; DOI: 10.1016/j.ijpharm.2015.01.006.
- 26. M. Desai, R. R. Jivani, L. D. Patel, N. P. Jivani and B. Sonagara, Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release, Int. J. Pharm. Investig.2 (2012) 208–212; DOI: 10.4103/2230-973x.107005.
- 27. S. Sungthongjeen, S. Puttipipatkhachorn, O. Paeratakul, A. Dashevsky and R. Bodmeier, Development of pulsatile release tablets with swelling and rupturable layers, J. Control. Release95 (2004) 147–159; DOI: 10.1016/j.jconrel..2003.10.023.
- 28. T. Bussemer, N. A. Peppas and R. Bodmeier, Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system, Eur. J. Pharm. Biopharm.56 (2003) 261–270; DOI: 10.1016/S0939-6411(03)00070-5.